GEODE CAPITAL MANAGEMENT, LLC

Position in CTNM — Contineum Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in CTNM

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$11,361,350

+$7,677,934 QoQ

Shares Held

693,188

+145.8% QoQ

Ownership

1.84%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 101 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. CTNM ranks #178 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,361,350	693,188	+145.8%	Shares	Defined	2026-08-12
2026-03-31	$3,683,416	282,038	+31.9%	Shares	Defined	2026-05-15
2025-12-31	$2,444,521	213,869	+1.3%	Shares	Defined	2026-02-09
2025-09-30	$2,479,837	211,050	+196.0%	Shares	Defined	2025-11-12
2025-06-30	$283,072	71,303	-63.1%	Shares	Defined	2025-08-08
2025-03-31	$1,347,495	193,051	+2.5%	Shares	Defined	2025-05-13
2024-12-31	$2,760,177	188,408	+46.4%	Shares	Defined	2025-02-12
2024-09-30	$2,462,858	128,676	-17.7%	Shares	Defined	2024-11-12
2024-06-30	$2,754,573	156,421	—	Shares	Defined	2024-08-09
No filing history on record for this holder in this stock.